Title of article
Multi-microarray identifies lower AQP9 expression in adjuvant chemotherapy nonresponders with stage III colorectal cancer
Author/Authors
Dou، نويسنده , , Ruoxu and Deng، نويسنده , , Yanhong and Huang، نويسنده , , Lanlan and Fu، نويسنده , , Shijun and Tan، نويسنده , , Shuyun and Wang، نويسنده , , Lei and Lian، نويسنده , , Lei and Fang، نويسنده , , Lekun and Fan، نويسنده , , Xinjuan and Jin، نويسنده , , Gang and Liu، نويسنده , , Huanliang and Wang، نويسنده , , Jianping، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2013
Pages
8
From page
106
To page
113
Abstract
Approximately 25% of stage III colorectal cancer patients do not benefit from standard adjuvant chemotherapies. To identify biomarkers for nonresponders, fresh-frozen tissues of 19 nonresponders and 16 responders were analyzed with gene expression and microRNA arrays. Fifty-nine genes and 17 miRNAs were differentially expressed by at least two folds. AQP9, SATB2, and WIF1 were simultaneously lower expressed in the nonresponders and modulated by the differentially expressed miRNAs. RT-PCR validated the differential expression of AQP9 (p = 0.035). In conclusion, lower AQP9 gene expression is related with non-response to adjuvant chemotherapy, showing potential as predictive marker and therapeutic target.
Keywords
Microarray , AQP9 , Chemosensitivity
Journal title
Cancer Letters
Serial Year
2013
Journal title
Cancer Letters
Record number
1823208
Link To Document